Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where S. Farrelly is active.

Publication


Featured researches published by S. Farrelly.


Schizophrenia Research | 2005

The relationship between duration of untreated psychosis and outcome: an eight-year prospective study.

Meredith Harris; Lisa Henry; Susy Harrigan; Rosemary Purcell; Orli Schwartz; S. Farrelly; A. Prosser; Henry J. Jackson; Patrick D. McGorry

Longer duration of untreated psychosis (DUP) prior to the initiation of treatment has been found to predict poorer short-term clinical and functional outcomes in patients with first-episode psychosis (FEP). The extent to which the relationship between DUP and outcome is maintained in the medium-to-long term however remains unclear. We examined the influence of DUP on clinical and functional outcomes in a prospective, naturalistic study of 318 FEP patients followed up 8 years after initial treatment at a specialist early psychosis service. Quality of life, social and occupational functioning, positive and negative symptoms at 8 years were assessed using standardized instruments. Multiple linear regression analyses indicated that, after controlling for the effects of other factors, shorter DUP correlated moderately with decreased severity of positive symptoms, and enhanced social and occupational functioning and quality of life. There was no uniform point associated with medium-to-long term impairment, with some domains of outcome more sensitive to treatment delay than others. However a consistent finding was that outcomes for these domains were significantly worse when DUP exceeded 3 months. Among those with a schizophrenia-spectrum diagnosis, DUP exceeding 1 year was associated with poorer outcome. No association was found between DUP and negative symptoms in either diagnostic group. As with short-term prognosis, DUP appears to be an independent predictor of prognosis in the medium-to-long term. Results support the need for assertive early detection strategies to facilitate the timely delivery of effective intervention programs to those with emerging psychotic illness in order to reduce the risk of long term deleterious outcomes.


The Journal of Clinical Psychiatry | 2010

The EPPIC Follow-Up Study of First-Episode Psychosis: Longer-Term Clinical and Functional Outcome 7 Years After Index Admission

Lisa Henry; G.P. Amminger; Meredith Harris; H.P. Yuen; Susy Harrigan; A. Prosser; Orli Schwartz; S. Farrelly; Helen Herrman; Henry J. Jackson; Patrick D. McGorry

OBJECTIVE To describe the longer-term clinical and functional outcome of a large, epidemiologic representative cohort of individuals experiencing a first episode of psychosis. METHOD A naturalistic, prospective follow-up of an epidemiologic sample of 723 consecutive first-episode psychosis patients, followed between January 1998 and April 2005, at a median of 7.4 years after initial presentation to the Early Psychosis Prevention and Intervention Centre (EPPIC) in Melbourne, Australia. EPPIC is a frontline public mental health early psychosis program, servicing a geographically defined catchment area with a population of about 800,000 people. The main outcome measures included the Brief Psychiatric Rating Scale, the Schedule for the Assessment of Negative Symptoms, the Beck Depression Inventory, the Global Assessment of Functioning Scale, the Social and Occupational Functioning Assessment Scale, the Quality of Life Scale, and the remission criteria developed by the Remission in Schizophrenia Working Group. RESULTS Follow-up information was collected on up to 90.0% (n = 651) of the baseline cohort of 723 participants, with 66.9% (n = 484) interviewed. In the last 2 years, 57% of individuals with schizophrenia/schizophreniform, 54% with schizoaffective disorder, 62% with affective psychosis, and 68% with other psychotic disorders reported some paid employment. Depending upon the criteria applied, symptomatic remission at follow-up was observed in 37%-59% of the cohort. Social/vocational recovery was observed in 31% of the cohort. Approximately a quarter achieved both symptomatic remission and social/vocational recovery. CONCLUSION The relatively positive outcomes are consistent with a beneficial effect of specialized early intervention programs; however it is premature to draw firm conclusions. There was no control group and there are many differences between the relevant comparison studies and the present one. Although difficult to conduct, large scale controlled health services research trials are required to definitively determine the impact and optimal duration of specialized early psychosis programs.


Schizophrenia Research | 2010

Suicide attempt in first-episode psychosis: A 7.4 year follow-up study

Jeff Robinson; Meredith Harris; Susy Harrigan; Lisa Henry; S. Farrelly; A. Prosser; Orli Schwartz; Henry J. Jackson; Patrick D. McGorry

BACKGROUND Individuals with first-episode psychosis demonstrate high rates of suicide attempt (SA). AIMS 1) To examine the prevalence of, and risk factors for, SA in a first-episode psychosis (FEP) cohort over a 7.4 year follow-up period. 2) To investigate differences between single versus multiple suicide attempters. METHODS This study reports baseline and follow-up data from a naturalistic, prospective follow-up of 413 FEP patients treated at a specialist early psychosis centre. Assessments were conducted at treatment entry, initial symptom remission or stabilization, and long term follow-up. Binary logistic regression models were used to assess unadjusted and adjusted associations between early illness and sociodemographic characteristics and two outcome measures: any SA during follow-up; and multiple SAs. RESULTS Follow-up data were available for 282 participants. Sixty-one (21.6%) made a suicide attempt over the follow-up period, including 12 successful suicides. The following baseline risk factors increased the risk of any SA: history of self-harm (OR=4.27; p<0.001), suicidal tendencies (OR=2.30; p=0.022), being depressed for >50% of the initial psychotic episode (OR=2.49; p=0.045), and hopelessness (OR=2.03; p=0.030). History of problem alcohol use increased the risk of multiple SAs (OR=4.43; 95% CI (1.05-18.7); p=0.043). DISCUSSION The prevalence of suicide attempt in this study exceeds reports from short-term FEP studies but is comparable to longer term follow-up studies, indicating that risk remains elevated for at least 7 years following commencement of treatment. The key predictor of future suicide attempt was previous self-harm, indicating that interventions for self-harm are required.


Early Intervention in Psychiatry | 2007

Early Psychosis Prevention and Intervention Centre long‐term follow‐up study of first‐episode psychosis: methodology and baseline characteristics

Lisa Henry; Meredith Harris; G. Paul Amminger; Hok Pan Yuen; Susy Harrigan; Martin Lambert; Philippe Conus; Orli Schwartz; A. Prosser; S. Farrelly; Rosemary Purcell; Helen Herrman; Henry J. Jackson; Patrick D. McGorry

Aim:  This paper reports the rationale, methodology and baseline characteristics of a large long‐term follow‐up study of first‐episode psychosis from a geographically defined catchment area.


Acta Psychiatrica Scandinavica | 2007

Prevalence and correlates of comorbidity 8 years after a first psychotic episode

S. Farrelly; Meredith Harris; Lisa Henry; Rosemary Purcell; A. Prosser; Orli Schwartz; Henry J. Jackson; Patrick D. McGorry

Objective:  While rates and correlates of comorbidity have been investigated in the early course of psychosis, little is known about comorbidity in the medium‐to‐longer term or its relationship with outcome.


Schizophrenia Bulletin | 2005

The 8 year functional and symptomatic outcome of first episode psychosis (FEP)

Lisa Henry; Meredith Harris; Orli Schwartz; S. Farrelly; A. Prosser; H.P. Yuen; Helen Herrman; Patrick D. McGorry

This is the Special Issue: Abstracts of the 20th International Congress on Schizophrenia Research 2005This journal issue entitled: Special Issue: Abstracts of the XX International Congress on Schizophrenia Research


Schizophrenia Bulletin | 2011

Quality of life as an outcome of psychosis: implications for recovery

Sue Cotton; John Gleeson; Mario Alvarez-Jimenez; Lisa Henry; Meredith Harris; S. Farrelly; Susy Harrigan; Patrick D. McGorry

Background: The large variation in individual clinical responses to antipsychotic treatment hampers the management of psychotic disorders. Genetic factors are considered a main cause of this variation. Pharmacogenetics studies have demonstrated significant associations between several candidate genes (a.o. D2, D3, 5HTR2A and 5HTR2C, GRM3, COMT and MTHFR) and the response to antipsychotic drugs. The present study investigates the effect of 12 polymorphisms for an association with antipsychotic treatment response in patients with a psychotic disorder. Methods: 335 Caucasian patients with a non-affective psychotic disorder using antipsychotics were included. All patients participated in the longitudinal GROUP-study in The Netherlands. We genotyped 12 SNPs in 7 candidate genes (DRD2: TaqI-A, TaqI-D, -141-C, C957T; DRD3: Ser9Gly; HTR2A: 102-T/C, His452Tyr; HTR2C: Cys23Ser, -759-T/C; COMT: Val108/158Met; MTHFR: 677-C/T, GRM3: rs274622) using standard protocols. Polymorphisms were based on previous studies showing associations with treatment response. The Clinical Global Impression- Schizophrenia scale was cross-sectionally used to assess improvement in positive psychotic symptoms since the start of current antipsychotic treatment. Ordinal regression was used to test for an association between polymorphisms and improvement in positive symptoms. All polymorphisms were tested in an additive model, with minor allele dose as the dependent variable. Results: Ninety percent of the patients used atypical antipsychotics, with olanzapine (31%) and risperidone (29%) being the most prescribed drugs. Ser9Gly of the dopamine D3 receptor gene (P value .029) and 677-C/T of MTHFR (P value .029) were tested significant. Gly carriers and T-carriers, respectively, showed better clinical improvement on the positive scale. All other polymorphisms did not show any association with treatment response (all P values >.10). Conclusion: We were able to replicate only two of the previously reported associations between polymorphisms and treatment response. Heterogeneity in patient samples and outcome variables as well as publication bias and false positive findings may all play a role in lack of replication, found in our study, as in others. The direction of the associations presented here in D3 (Ser9Gly) and MTHFR (677-C/T) are in line with previous association studies in Caucasian patients. These polymorphisms may be of value for predicting clinical response.


Schizophrenia Research | 2004

Are the effects of duration of untreated psychosis (DUP) on psychopathology and functional outcome at 12-month follow-up maintained at 6-8-year follow-up?

Meredith Harris; Lisa Henry; Susy Harrigan; Orli Schwartz; S. Farrelly; A. Prosser; Patrick D. McGorry

DAYLY PROGRAM Mornings Lectures: 1. Key Notes: 20 minutes each, written in italics; 2. Normal Lectures: 15 min. each 3. Short Communications: 10 min. Afternoons Group discussions in different halls and Conclusions in Plenum Discussions The discussions will be carried out in maximum of 5 groups. The definitive topics and groups will be determined in the morning. Friday: 1. Sustainable beekeeping, 2. Organic Beekeeping Management: General, 3. Demeter, 4. ev. Other organic management techniques Saturday: 1. Disease control by a. Drugs and b. Selection and Management; 2. Bee Products and Apitherapy; 3. Environment Sunday: Discussions are after the corresponding sessions


Schizophrenia Research | 2012

Poster #240 QUALITY OF LIFE AS AN OUTCOME OF PSYCHOSIS: IMPLICATIONS FOR RECOVERY

Sue Cotton; John Gleeson; Mario Alvarez-Jimenez; Lisa Henry; Meredith Harris; S. Farrelly; Susy Harrigan; Patrick D. McGorry


Schizophrenia Research | 2008

Findings from the EPPIC long-term follow-up study of first episode psychosis: Baseline predictors of the deficit syndrome at the long-term outcome

Lisa Henry; Helen Herrman; H.P. Yuen; Meredith Harris; S. Farrelly; A. Prosser; Orli Schwartz; Henry J. Jackson; Patrick D. McGorry

Collaboration


Dive into the S. Farrelly's collaboration.

Top Co-Authors

Avatar

Lisa Henry

University of Melbourne

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A. Prosser

University of Melbourne

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

H.P. Yuen

University of Melbourne

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge